Health News – Pfizer progress on Omicron-specific vaccine
A key COVID-19 vaccine trial is now underway, and it’s raising questions about the future of coronavirus prevention.
Pfizer and Biotech just announced the start of a clinical trial for a new vaccine engineered to specifically target the Omicron variant.
Today’s Health News has more.
